Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.13
Delayed Data
As of Apr 21
 -0.0299 / -2.58%
Today’s Change
1.04
Today|||52-Week Range
2.89
+4.64%
Year-to-Date
Institutional investors purchased a net $2.2 million shares of GENE during the quarter ended December 2016 and now own 16.93% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional16.90%
Mutual fund holders0.03%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2017SIMPLEX TRADING LLC  Bought 3.4 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC6.59%1,070,3331,284,400+1,070,333--
Heights Capital Management, Inc.5.69%923,3581,108,030+923,358--
Renaissance Technologies LLC4.18%679,080814,896+192,400+39.53%
Two Sigma Securities LLC0.30%49,00758,808+49,007--
Arxis Securities LLC0.07%11,87514,250+11,875--
Cutler Group LP0.03%4,8005,76000.00%
Simplex Trading LLC0.03%4,3125,174+3,356+351.05%
KMS Financial Services, Inc.0.02%2,7503,30000.00%
Morgan Stanley Smith Barney LLC (...0.01%1,5001,800+500+50.00%
UBS Financial Services, Inc.0.01%1,0001,20000.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Trust for Professional Managers -...0.03%5,5466,655+5,546--